Article
Biotechs face brutal pipeline decisions as industry waits for M&A 'buffet'
Rating:
0.0
Views:
21
Likes:
1
Library:
1
On biotech's cutting room floor lies a littering of IV bags and powdery oral pills. Cast off trial documents and FDA regulatory submissions, hastily pulled back, are piling up in the recycling. | We're seeing a seemingly unprecedented reckoning from biotech C-suites, where executives are making tough calls about continuing to keep the lights on or cutting once-promising candidates.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value